German China India

Global Partnership

Sandoz Partners with Biocon for Next-Generation Biosimilars

| Editor: Ahlam Rais

Sandoz will lead commercialization in North America and the EU, while Biocon will lead commercialization in Rest of the World.
Gallery: 1 image
Sandoz will lead commercialization in North America and the EU, while Biocon will lead commercialization in Rest of the World. (Bild: Deposit Photos)

The collaboration aims to leverage the combined strengths of development, manufacturing and commercialization of biosimilars. The move is expected to benefit patients across the globe.

Holzkirchen/Germany – Sandoz, a Novartis division and the global leader in biosimilars, has recently announced a global partnership with Asia’s premier biopharmaceuticals company, Biocon. With this, both the companies will develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Under the terms of the agreement, the companies will also share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products, and will have a cost and profit share arrangement globally. Worldwide commercialization responsibilities will be divided and each company’s strengths will be leveraged within specific geographies. Sandoz will lead commercialization in North America and the EU, while Biocon will lead commercialization in Rest of the World.

Comments are being loaded ....

Leave a comment

The comment is checked by an editor and will be released soon.

  1. Avatar
    Avatar
    Edited by at
    Edited by at
    1. Avatar
      Avatar
      Edited by at
      Edited by at

Comments are being loaded ....

Report comment

Kommentar Freigeben

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

Freigabe entfernen

Der untenstehende Text wird an den Kommentator gesendet, falls dieser eine Email-hinterlegt hat.

copyright

This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 45110282 / Pharma & Food)